The ins and outs of pertussis toxin

FEBS Journal

Volumn 278, Issue 23, 2011, Pages 4668-4682

  Locht, Camille ^a   Coutte, Loic ^a   Mielcarek, Nathalie ^a  

^a UNIV LILLE   (France)

Author keywords

A B toxins; ADP ribosylation; retrograde transport; type IV secretion system; whooping cough

Indexed keywords

BACTERIAL PROTEIN; INNER MEMBRANE PROTEIN; MEMBRANE PROTEIN; OUTER MEMBRANE PROTEIN; PERIPLASMIC PROTEIN; PERTUSSIS TOXIN; PERTUSSIS VACCINE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ADENOSINE DIPHOSPHATE RIBOSYLATION; BACTERIAL COLONIZATION; BACTERIUM PILUS; CELL MIGRATION; CONFORMATIONAL TRANSITION; GENETIC TRANSCRIPTION; HUMAN; INNATE IMMUNITY; MEMBRANE BINDING; NONHUMAN; PERTUSSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; REVIEW; TOXIN STRUCTURE; TOXIN SYNTHESIS; TRANSLATION REGULATION; VACCINATION;

ADENOSINE DIPHOSPHATE; ANIMALS; BORDETELLA PERTUSSIS; ENDOCYTOSIS; GTP-BINDING PROTEINS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; MODELS, MOLECULAR; PERTUSSIS TOXIN; PROTEIN BIOSYNTHESIS; PROTEIN CONFORMATION; PROTEIN TRANSPORT; TRANSCRIPTION, GENETIC; VIRULENCE FACTORS, BORDETELLA;

BACTERIA (MICROORGANISMS); BORDETELLA PERTUSSIS;

EID: 81555197168     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2011.08237.x     Document Type: Review

References (153)

1. Marchitto KS, Smith SG, Locht C, &, Keith JM, (1987) Nucleotide sequence homology to pertussis toxin gene in Bordetella bronchiseptica and Bordetella parapertussis. Infect Immun 55, 497-501. (Pubitemid 17021930)
2. Aricò B, &, Rappuoli R, (1987) Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J Bacteriol 169, 2847-2853. (Pubitemid 17104355)
3. Toomey JA, &, McClelland JE, (1933) Pertussis toxin or antigen. Proc Soc Exp Biol Med 31, 34-35.
4. Banerjea A, &, Munoz J, (1962) Antigens of Bordetella pertussis. II. Purification of heat-labile toxin. J Bacteriol 84, 269-274.
5. Bordet J, &, Gengou O, (1909) L'endotoxine coquelucheuse. Ann Inst Pasteur 23, 415-419.
6. Pittman M, (1979) Pertussis toxin: the cause of the harmful effects and prolonged immunity of whooping cough. A hypothesis. Rev Infect Dis 1, 401-412.
7. Katada T, &, Ui M, (1982) ADP ribosylation of the specific membrane protein of C6 cells by islet-activating protein associated with modification of adenylate cyclase activity. J Biol Chem 257, 7210-7216.
8. Bokoch GM, Katada T, Northup JK, Hewlett EL, &, Gilman AG, (1983) Identification of the predominant substrate for ADP-ribosylation by islet activating protein. J Biol Chem 258, 2072-2075.
9. Tamura M, Nogimori K, Murai S, Yajima M, Ito K, Katada T, Ui M, &, Ishii S, (1982) Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. Biochemistry 21, 5516-5522. (Pubitemid 13205429)
10. Locht C, &, Keith JM, (1986) Pertussis toxin gene: nucleotide sequence and genetic organization. Science 232, 1258-1264. (Pubitemid 16066003)
11. Nicosia A, Perugini M, Franzini C, Casagli MC, Borri MG, Antoni G, Almoni M, Neri P, Ratti G, &, Rappuoli R, (1986) Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Proc Natl Acad Sci USA 83, 4631-4635. (Pubitemid 16075455)
12. Stein PE, Boodhoo A, Armstrong GD, Cockle SA, Klein MH, &, Read RJ, (1994) The crystal structure of pertussis toxin. Structure 2, 45-57.
13. Raze D, Veithen A, Sato H, Antoine R, Menozzi FD, &, Locht C, (2006) Genetic exchange of the S2 and S3 subunits in pertussis toxin. Mol Microbiol 60, 1242-1250.
14. Weiss AA, Johnson FD, &, Burns DL, (1993) Molecular characterization of an operon required for pertussis toxin secretion. Proc Natl Acad Sci USA 90, 2970-2974. (Pubitemid 23113539)
15. Stibitz S, (2007) The bvg regulon. In Bordetella Molecular Microbiology (, Locht C, ed.), pp. 47-67. Bioscience, Norfolk, UK.
16. Farizo KM, Fiddner S, Cheung AM, &, Burns DL, (2002) Membrane localization of the S1 subunit of pertussis toxin in Bordetella pertussis and implications for pertussis toxin secretion. Infect Immun 70, 1193-1201. (Pubitemid 34163391)
17. Rambow-Larsen AA, &, Weiss AA, (2004) Temporal expression of pertussis toxin and Ptl secretion proteins by Bordetella pertussis. J Bacteriol 186, 43-50. (Pubitemid 38020285)
18. Stenson TH, &, Weiss AA, (2002) DsbA and DsbC are required for secretion of pertussis toxin by Bordetella pertussis. Infect Immun 70, 2297-2303. (Pubitemid 34408368)
19. Stenson TH, Patton AK, &, Weiss AA, (2003) Reduced glutathione is required for pertussis toxin secretion by Bordetella pertussis. Infect Immun 71, 1316-1320. (Pubitemid 36254316)
20. Antoine R, &, Locht C, (1990) Roles of the disulfide bond and the carboxy-terminal region of the S1 subunit in the assembly and biosynthesis of pertussis toxin. Infect Immun 58, 1518-1526. (Pubitemid 20176332)
21. Burnette WN, Arciniega JL, Mar VL, &, Burns DL, (1992) Properties of pertussis toxin B oligomer assembled in vitro from recombinant polypeptides produced by Escherichia coli. Infect Immun 60, 2252-2256.
22. Burns DL, Fiddner S, Cheung AM, &, Verma A, (2004) Analysis of subassemblies of pertussis toxin subunits in vivo and their interaction with the Ptl transport apparatus. Infect Immun 72, 5365-5372. (Pubitemid 39223425)
23. Nencioni L, Pizza MG, Volpini G, De Magistris MT, Giovannoni F, &, Rappuoli R, (1991) Properties of the B oligomer of pertussis toxin. Infect Immun 59, 4732-4734.
24. Farizo KM, Huang T, &, Burns DL, (2000) Importance of holotoxin assembly in Ptl-mediated secretion of pertussis toxin from Bordetella pertussis. Infect Immun 68, 4049-4054. (Pubitemid 30434559)
25. Backert S, &, Meyer TF, (2006) Type IV secretion systems and their effectors in bacterial pathogenesis. Curr Opin Microbiol 9, 207-217.
26. Burns DL, (2003) Type IV transporters of pathogenic bacteria. Curr Opin Microbiol 6, 29-34. (Pubitemid 36258533)
27. Llosa M, Roy C, &, Dehio C, (2009) Bacterial type IV secretion systems in human disease. Mol Microbiol 73, 141-151.
28. Pantoja M, Chen L, Chen Y, &, Nester EW, (2002) Agrobacterium type IV secretion is a two-step process in which export substrates associate with the virulence protein VirJ in the periplasm. Mol Microbiol 45, 1325-1335. (Pubitemid 35015356)
29. Craig-Mylius KA, Stenson TH, &, Weiss AA, (2000) Mutations in the S1 subunit of pertussis toxin that affect secretion. Infect Immun 68, 1276-1281. (Pubitemid 30108522)
30. Craig-Mylius KA, &, Weiss A, (1999) Mutants in the ptlA-H genes of Bordetella pertussis are deficient for pertussis toxin secretion. FEMS Microbiol Lett 179, 479-484. (Pubitemid 29460716)
31. Cook DM, Farizo KM, &, Burns DL, (1999) Identification and characterization of PtlC, an essential component of the pertussis toxin secretion system. Infect Immun 67, 754-759. (Pubitemid 29059215)
32. Kotob SI, &, Burns DL, (1997) Essential role of the consensus nucleotide-binding site of PtlH in secretion of pertussis toxin from Bordetella pertussis. J Bacteriol 179, 7577-7580. (Pubitemid 27509999)
33. Durand E, Waksman G, &, Receveur-Brechot V, (2011) Structural insights into the membrane-extracted dimeric form of the ATPase TraB from the Escherichia coli pKM101 conjugation system. BMC Struct Biol 11, 4.
34. Durand E, Oomen C, &, Waksman G, (2010) Biochemical dissection of the ATPase TraB, the VirB4 homologue of the Escherichia coli pKM101 conjugation machinery. J Bacteriol 192, 2315-2323.
35. Ward DV, Draper O, Zupan JR, &, Zambryski PC, (2002) Peptide linkage mapping of the Agrobacterium tumefaciens vir-encoded type IV secretion system reveals protein subassemblies. Proc Natl Acad Sci USA 99, 11493-11500. (Pubitemid 34920952)
36. Dang TA, Zhou XR, Graf B, &, Christie PJ, (1999) Dimerization of the Agrobacterium tumefaciens VirB4 ATPase and the effect of ATP-binding cassette mutations on the assembly and function of the T-DNA transporter. Mol Microbiol 32, 1239-1253. (Pubitemid 29286663)
37. Verma A, &, Burns DL, (2007) Requirements for assembly of PtlH with the pertussis toxin transporter apparatus of Bordetella pertussis. Infect Immun 75, 2297-2306. (Pubitemid 46744318)
38. Savvides SN, Yeo H-J, Beck MR, Blaesing F, Lurz R, Lanka E, Buhrdorf R, Fischer W, Haas R, &, Waksman G, (2003) VirB11 ATPases are dynamic hexameric assemblies: new insights into bacterial type IV secretion. EMBO J 22, 1969-1980. (Pubitemid 36565523)
39. Yeo HJ, Savvides SN, Herr AB, Lanka E, &, Waksman G, (2000) Crystal structure of the hexameric traffic ATPase of the Helicobacter pylori type IV secretion system. Mol Cell 6, 1461-1472. (Pubitemid 32045937)
40. Jakubowski SJ, Krishnamoorthy V, &, Christie PJ, (2003) Agrobacterium tumefaciens VirB6 protein participates in formation of VirB7 and VirB9 complexes required for type IV secretion. J Bacteriol 185, 2867-2878. (Pubitemid 36514598)
41. Hapfelmeier S, Domke N, Zambryski PC, &, Baron C, (2000) VirB6 is required for stabilization of VirB5 and VirB3 and formation of VirB7 homodimers in Agrobacterium tumefaciens. J Bacteriol 182, 4505-4511. (Pubitemid 30599814)
42. Verma A, Cheung AM, &, Burns DL, (2008) Stabilization of the pertussis toxin secretion apparatus by the C terminus of PtlD. J Bacteriol 190, 7285-7290.
43. Johnson FD, &, Burns DL, (1994) Detection and subcellular localization of three Ptl proteins involved in the secretion of pertussis toxin from Bordetella pertussis. J Bacteriol 176, 5350-5356. (Pubitemid 24273522)
44. Chandran V, Fronzes R, Duquerroy S, Cronin N, Navaza J, &, Waksman G, (2009) Structure of the outer membrane complex of a type IV secretion system. Nature 462, 1011-1015.
45. Cascales E, &, Christie PJ, (2004) Agrobacterium VirB10, an ATP energy sensor required for type IV secretion. Proc Natl Acad Sci USA 101, 17228-17233. (Pubitemid 39627802)
46. Bayer M, Iberer R, Bischof K, Rassi E, Stabentheiner E, Zellnig G, &, Koraimann G, (2001) Functional and mutational analysis of P19, a DNA transfer protein with muramidase activity. J Bacteriol 183, 3176-3183. (Pubitemid 32433536)
47. Nambu T, Minamino T, Macnab RM, &, Kutsukake K, (1999) Peptidoglycan-hydrolyzing activity of the FlgJ protein, essential for flagellar rod formation in Salmonella typhimurium. J Bacteriol 181, 1555-1561. (Pubitemid 29110816)
48. Zahrl D, Wagner M, Bischof K, Bayer M, Zavecz B, Beranek A, Ruckenstuhl C, Zarfel GE, &, Koraimann G, (2005) Peptidoglycan degradation by specialized lytic transglycosylases associated with type III and type IV secretion systems. Microbiology 151, 3455-3467. (Pubitemid 41632060)
49. Rambow-Larsen AA, &, Weiss AA, (2002) The PtlE protein of Bordetella pertussis has peptidoglycanase activity required for Ptl-mediated pertussis toxin secretion. J Bacteriol 184, 2863-2869. (Pubitemid 34517807)
50. Jones AL, Shirasu K, &, Kado CI, (1994) The product of the virB4 gene of Agrobacterium tumefaciens promotes accumulation of VirB3 protein. J Bacteriol 176, 5255-5261. (Pubitemid 24273510)
51. Shirasu K, &, Kado CI, (1993) Membrane location of the Ti plasmid VirB proteins involved in the biosynthesis of a pilin-like conjugative structure on Agrobacterium tumefaciens. FEMS Microbiol Lett 111, 287-293.
52. Mossey P, Hudacek A, &, Das A, (2010) Agrobacterium tumefaciens type IV secretion protein VirB3 is an inner membrane protein and requires VirB4, VirB7, and VirB8 for stabilization. J Bacteriol 192, 2830-2838.
53. Farizo KM, Cafarella TG, &, Burns DL, (1996) Evidence for a ninth gene, ptlI, in the locus encoding the pertussis toxin secretion system of Bordetella pertussis and formation of a PtlI-PtlF complex. J Biol Chem 271, 31643-31649. (Pubitemid 26408627)
54. Sankaran K, &, Wu HC, (1994) Lipid modification of bacterial prolipoprotein. Transfer of diacylglyceryl moiety from phosphatidylglycerol. J Biol Chem 269, 19701-19706.
55. Seydel A, Gounon P, &, Pugsley AP, (1999) Testing the '+2 rule' for lipoprotein sorting in the Escherichia coli cell envelope with a new genetic selection. Mol Microbiol 34, 810-821.
56. Bayliss R, Harris R, Coutte L, Monier A, Fronzes R, Christie PJ, Driscoll PC, &, Waksman G, (2007) NMR structure of a complex between the VirB9/VirB7 interaction domains of the pKM101 type IV secretion system. Proc Natl Acad Sci USA 104, 1673-1678. (Pubitemid 46214649)
57. Fronzes R, Schafer E, Wang L, Saibil HR, Orlova EV, &, Waksman G, (2009) Structure of a type IV secretion system core complex. Science 323, 266-268.
58. Lai EM, &, Kado CI, (1998) Processed VirB2 is the major subunit of the promiscuous pilus of Agrobacterium tumefaciens. J Bacteriol 180, 2711-2717. (Pubitemid 28213271)
59. Aly KA, &, Baron C, (2007) The VirB5 protein localizes to the T-pilus tips in Agrobacterium tumefaciens. Microbiology 153, 3766-3775. (Pubitemid 350168255)
60. Burns DL, (1999) Biochemistry of type IV secretion. Curr Opin Microbiol 2, 25-29. (Pubitemid 29130210)
61. Eisenbrandt R, Kalkum M, Lai E-M, Lurz R, Kado CI, &, Lanka E, (1999) Conjugative pili of IncP plasmids, and the Ti plasmid T pilus are composed of cyclic subunits. J Biol Chem 274, 22548-22555.
62. Lai EM, Eisenbrandt R, Kalkum M, Lanka E, &, Kado CI, (2002) Biogenesis of T pili in Agrobacterium tumefaciens requires precise VirB2 propilin cleavage and cyclization. J Bacteriol 184, 327-330. (Pubitemid 34003315)
63. Haase J, &, Lanka E, (1997) A specific protease encoded by the conjugative DNA transfer systems of IncP and Ti plasmids is essential for pilus synthesis. J Bacteriol 179, 5728-5735. (Pubitemid 27398271)
64. Armstrong GD, Howard LA, &, Peppler MS, (1988) Use of glycosyltransferases to restore pertussis toxin receptor activity to asialogalactofetuin. J Biol Chem 263, 8677-8684.
65. Hausman SZ, &, Burns DL, (1993) Binding of pertussis toxin to lipid vesicls containing glycolipids. Infect Immun 61, 335-337. (Pubitemid 23015437)
66. Bogdan JA, Yuan W, Long-Rowe KO, Sarwar J, Brucker EA, &, Blake MS, (2003) Identification of peptides that mimic the pertussis toxin binding site on bovine fetuin. Appl Environ Microbiol 69, 6272-6279. (Pubitemid 37280355)
67. Rogers TS, Corey SJ, &, Rosoff PM, (1990) Identification of a 43-kilodalton human T lymphocyte membrane protein as a receptor for pertussis toxin. J Immunol 145, 678-683. (Pubitemid 20252379)
68. El Baya A, Linnemann R, von Olleschik-Elbheim L, &, Schmidt MA, (1995) Identification of binding proteins for pertussis toxin on pancreatic and ß cell-derived insulin-secreting cells. Microb Pathog 18, 173-185.
69. Brennan MJ, David JL, Kenimer JG, &, Manclark CR, (1988) Lectin-like binding of pertussis toxin to a 165-kilodalton Chinese hamster ovary cell glycoprotein. J Biol Chem 263, 4895-4899.
70. Stein PE, Boodhoo A, Armstrong GD, Heerze LD, Cockle SA, Klein MH, &, Read RJ, (1994) Structure of a pertussis toxin-sugar complex as a model for receptor binding. Nat Struct Biol 1, 591-596.
71. Lobet Y, Feron C, Duquesne G, Simoen E, Hauser P, &, Locht C, (1993) Site-specific alterations in the B-oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin. J Exp Med 177, 79-87. (Pubitemid 23008087)
72. Saukkonen K, Burnette WN, Mar VL, Masure HR, &, Tuomanen EI, (1992) Pertussis toxin has eukaryotic-like carbohydrate recognition domains. Proc Natl Acad Sci USA 89, 118-122.
73. Rossjohn J, Buckley JT, Hazes B, Murzin AG, Read RJ, &, Parker MW, (1997) Aerolysin and pertussis toxin share a common receptor-binding domain. EMBO J 16, 3426-3434. (Pubitemid 27250038)
74. Loosmore S, Zealey G, Cockle S, Boux H, Chong P, Yacoob R, &, Klein M, (1993) Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits. Infect Immun 61, 2316-2324. (Pubitemid 23159217)
75. Xu Y, &, Barbieri JT, (1995) Pertussis toxin-mediated ADP-ribosylation of target proteins in Chinese hamster ovary cells involves a vesicle trafficking mechanism. Infect Immun 63, 825-832.
76. El Baya A, Linnemann R, von Olleschik-Elbheim L, Robenek H, &, Schmidt MA, (1997) Endocytosis and retrograde transport of pertussis toxin to the Golgi complex as a prerequisite for cellular intoxication. Eur J Cell Biol 73, 40-48. (Pubitemid 27226189)
77. i-3 in CHO cells is modulated by inhibitors of intracellular trafficking. Infect Immun 64, 593-599.
78. Hausman SZ, &, Burns DL, (2002) Interaction of pertussis toxin with cells and model membranes. J Biol Chem 267, 13735-13739.
79. Plaut RD, &, Carbonetti NH, (2008) Retrograde transport of pertussis toxin in the mammalian cell. Cell Microbiol 10, 1130-1139. (Pubitemid 351524277)
80. Castro MG, McNamara U, &, Carbonetti NH, (2001) Expression, activity, and cytotoxicity of pertussis toxin S1 subunit in transfected mammalian cells. Cell Microbiol 3, 45-54. (Pubitemid 32107425)
81. Veithen A, Raze D, &, Locht C, (2000) Intracellular trafficking and membrane translocation of pertussis toxin into host cells. Int J Med Microbiol 290, 409-413.
82. Hazes B, Boodhoo A, Cockle SA, &, Read RJ, (1996) Crystal structure of the pertussis toxin-ATP complex: a molecular sensor. J Mol Biol 258, 661-671. (Pubitemid 26145909)
83. Hazes B, &, Read RJ, (1997) Accumulating evidence suggests that several A-B toxins subvert the ER-associated protein degradation pathway to enter target cells. Biochemistry 37, 11051-11054. (Pubitemid 27398423)
84. Braakman I, Helenius J, &, Helenius A, (1992) Role of ATP and disulphide bonds during protein foding in the endoplasmic reticulum. Nature 356, 260-262.
85. Burns DL, &, Manclark CR, (1986) Adenine nucleotides promote dissociation of pertussis toxin subunits. J Biol Chem 261, 4324-4327. (Pubitemid 17198875)
86. Moss J, Stanley SJ, Burns DL, Hsia JA, Yost DA, Myers GA, &, Hewlett EL, (1983) Activation by thiol of the latent NAD glycohydrolase and ADP-ribosyltransferase activities of Bordetella pertussis toxin (islet-activating protein). J Biol Chem 258, 11879-11882.
87. Pande AH, Moe D, Jamnadas M, Tatulian SA, &, Teter K, (2006) The pertussis toxin S1 subunit is a thermally unstable protein susceptible to degradation by the 20S proteasome. Biochemistry 45, 13734-13740. (Pubitemid 44788743)
88. Hsia JA, Tsai SC, Adamik R, Yost DA, Hewlett EL, &, Moss J, (1983) Amino acid-specific ADP-ribosylation. Sensitivity to hydroxylamine of [cysteine(ADP-ribose)] protein and [arginine(ADP-ribose)]protein linkages. J Biol Chem 260, 16187-16191. (Pubitemid 16177005)
89. Graf R, Codina J, &, Birnbaumer L, (1992) Peptide inhibitors of ADP-ribosylation by pertussis toxin are substrates with affinities comparable to those of trimeric GTP-binding proteins. Mol Pharmacol 42, 760-764. (Pubitemid 23021478)
90. Locht C, &, Antoine R, (1995) A proposed mechanism of ADP-ribosylation catalyzed by the pertussis toxin S1 subunit. Biochimie 77, 333-340.
91. Cortina G, Krueger KM, &, Barbieri JT, (1991) The carboxyl terminus of the S1 subunit of pertussis toxin confers high affinity binding to transducin. J Biol Chem 266, 23810-23814. (Pubitemid 21908869)
92. Locht C, Lobet Y, Feron C, Cieplak W, &, Keith JM, (1990) The role of cysteine 41 in the enzymatic activities of the pertussis toxin S1 subunit as investigated by site-directed mutagenesis. J Biol Chem 265, 4552-4559.
93. Cortina G, &, Barbieri JT, (1989) Role of tryptophan 26 in the NAD glycohydrolase reaction of the S1-subunit of pertussis toxin. J Biol Chem 264, 17322-17328. (Pubitemid 19255563)
94. Locht C, Capiau C, &, Feron C, (1989) Identification of amino acid residues essential for the enzymatic activities of pertussis toxin. Proc Natl Acad Sci USA 86, 3075-3079. (Pubitemid 19129561)
95. Burnette WN, Cieplak W, Mar VL, Kaljot K, Sato H, &, Keith JM, (1988) Pertussis toxin S1 mutant with reduced enzyme activity and a conserved protective epitope. Science 242, 72-74.
96. Antoine R, &, Locht C, (1994) The NAD-glycohydrolase activity of the pertussis toxin S1 subunit: involvement of the catalytic His-35 residue. J Biol Chem 269, 6450-6457.
97. Xu Y, Brabançon-Fink V, &, Barbieri JT, (1994) Role of histidine 35 of the S1 subunit of pertussis toxin in the ADP-ribosylation of transducin. J Biol Chem 269, 9993-9999.
98. Antoine R, Tallett A, Van Heyningen S, &, Locht C, (1993) Evidence for a catalytic role of glutamic acid 129 in the NAD-glycohydrolase activity of the pertussis toxin S1 subunit. J Biol Chem 268, 24149-24155. (Pubitemid 23335398)
99. i3C20. Biochemistry 36, 8215-8223. (Pubitemid 27297530)
100. Zhou GC, Parikh SL, Tyler PC, Evans GB, Furneaux RH, Zubkova OV, Benjes PA, &, Schramm VL, (2004) Inhibitors of ADP-ribosylating bacterial toxins based on oxocarbenium ion character at their itransition states. J Am Chem Soc 126, 5690-5698. (Pubitemid 38621407)
101. Cieplak W, Locht C, Mar VL, Burnette WN, &, Keith JM, (1990) Photolabelling of mutant forms of the S1 subunit of pertussis toxin with NAD+. Biochem J 268, 547-551. (Pubitemid 20196933)
102. Cockle SA, (1989) Identification of an active site-residue in the S1 subunit of pertussis toxin by photocrosslinking with NAD. FEBS Lett 249, 329-332.
103. Bell CE, &, Eisenberg D, (1996) Crystal structure of diphtheria toxin bound to nicotinamide adenine dinucleotide. Biochemistry 35, 1137-1149. (Pubitemid 26050775)
104. Scheuring J, &, Schramm VL, (1997) Kinetic isotope effect characterization of the transition state for oxidized nicotinamide adenine dinucleotide hydrolysis by pertussis toxin. Biochemistry 36, 4526-4534. (Pubitemid 27180300)
105. Tuomanen E, Weiss A, Rich R, Zak F, &, Zak O, (1985) Filamentous hemagglutinin and pertussis toxin promote adherence of Bordetella pertussis to cilia. Dev Biol Stand 61, 197-204. (Pubitemid 16110295)
106. Tuomanen E, &, Weiss A, (1985) Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells. J Infect Dis 152, 118-125. (Pubitemid 15038843)
107. Millen SH, Lewallen DM, Herr AB, Iyer SS, &, Weiss AA, (2010) Identification and characterization of the carbohydrate ligands recognized by pertussis toxin via a glycan microarray and surface plasmon resonance. Biochemistry 49, 5954-5967.
108. van den Berg BM, Beekhuizen H, Willems RJ, Mooi FR, &, van Furth R, (1999) Role of Bordetella pertussis virulence factors in adherence to epithelial cell lines derived from the human respiratory tract. Infect Immun 67, 1056-1062. (Pubitemid 29108477)
109. Alonso S, Pethe K, Mielcarek N, Raze D, &, Locht C, (2001) Role of ADP-ribosyltransferase activity of pertussis toxin in toxin-adhesin redundancy with filamentous hemagglutinin during Bordetella pertussis infection. Infect Immun 69, 6038-6043. (Pubitemid 32885163)
110. Carbonetti NH, Artamonova GV, Mays RM, &, Worthington ZE, (2003) Pertussis toxin plays an early role in respiratory tract colonization by Bordetella pertussis. Infect Immun 71, 6358-6366. (Pubitemid 37337694)
111. Akira S, (2003) Toll-like receptor signaling. J Biol Chem 278, 38105-38108. (Pubitemid 37221695)
112. Fan H, Peck OM, Tempel GE, Halushka PV, &, Cook JA, (2004) Toll-like receptor 4 coupled GI protein signaling pathways regulate extracellular signal-regulated kinase phosphorylation and AP-1 activation independent of NFkappaB activation. Shock 22, 57-62. (Pubitemid 40228211)
113. Wang ZY, Yang D, Chen Q, Leifer CA, Segal DM, Su SB, Caspi RR, Howard ZO, &, Oppenheim JJ, (2006) Induction of dendritic cell maturation by pertussis toxin and its B subunit differentially initiate Toll-like receptor 4-dependent signal transduction pathways. Exp Hematol 34, 1115-1124. (Pubitemid 44080388)
114. Nasso M, Fedele G, Spensieri F, Palazzo R, Costantino P, Rappuoli R, &, Ausiello CM, (2009) Genetically detoxified pertussis toxin induces Th1/Th17 immune response through MAPKs and IL-10-dependent mechanisms. J Immunol 183, 1892-1899.
115. Kirimanjeswara GS, Mann PB, Pilione M, Kennett MJ, &, Harvill ET, (2005) The complex mechanism of antibody-mediated clearance of Bordetella from the lungs requires TLR4. J Immunol 175, 7504-7511. (Pubitemid 41713448)
116. Kirimanjeswara GS, Agosto LM, Kennett MJ, Bjornstad ON, &, Harvill ET, (2005) Pertussis toxin inhibits neutrophil recruitment to delay antibody-mediated clearance of Bordetella pertussis. J Clin Invest 115, 3594-3601. (Pubitemid 43121848)
117. Andreasen C, &, Carbonetti NH, (2008) Pertussis toxin inhibits early chemokine production to delay neutrophil recruitment in response to Bordetella pertussis respiratory tract infection in mice. Infect Immun 76, 5139-5148.
118. Brito GA, Souza MH, Melo-Filho AA, Hewlett EL, Lima AA, Flores CA, &, Ribeiro RA, (1997) Role of pertussis toxin A subunit in neutrophil migration and vascular permeability. Infect Immun 65, 1114-1118. (Pubitemid 27088020)
119. Spangrude GJ, Sacchi F, Hill HR, Van Epps DE, &, Daynes RA, (1985) Inhibition of lymphocyte and neutrophil chemotaxis by pertussis toxin. J Immunol 135, 4135-4143. (Pubitemid 16250403)
120. Alfano M, Schmidtmayerova H, Amella CA, Pushkarsky T, &, Bukrinsky M, (1999) The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains. J Exp Med 190, 597-605. (Pubitemid 29428644)
121. Schneider OD, Weiss AA, &, Miller WE, (2009) Pertussis toxin signals through the TCR to initiate cross-desensitization of the chemokine receptor CSCR4. J Immunol 182, 5730-5739.
122. Hoebe K, Janssen E, &, Beutler B, (2004) The interface between innate and adaptive immunity. Nat Immunol 5, 971-974. (Pubitemid 41057712)
123. Hou W, Wu Y, Sun S, Shi M, Sun Y, Yang C, Pei G, Gu Y, Zhong C, &, Sun B, (2003) Pertussis toxin enhances Th1 responses by stimuation of dendritic cells. J Immunol 170, 1728-1736. (Pubitemid 36197387)
124. Bagley KC, Abdelwahab SF, Tuskan RG, Fouts TR, &, Lewis GK, (2002) Pertussis toxin and the adenylate cyclase toxin from Bordetella pertussis activate human monocyte-derived dendritic cells and dominantly inhibit cytokine production through a cAMP-dependent pathway. J Leukoc Biol 72, 962-969. (Pubitemid 35365170)
125. Denkinger CM, Denkinger MD, &, Forsthuber TG, (2007) Pertussis toxin-induced cytokine differentiation and clonal expansion of T cells is mediated predominantly via costimulation. Cell Immunol 246, 46-54. (Pubitemid 47087770)
126. Ryan M, McCarthy L, Rappuoli R, Mahon BP, &, Mills KH, (1998) Pertussis toxin potentiates Th1 and Th2 responses to co-injected antigen: adjuvant action is associated with enhanced regulatory cytokine production and expression of the co-stimulatory molecules B7-1, B7-2 and CD28. Int Immunol 10, 651-662. (Pubitemid 28221466)
127. Hofstetter HH, Shive CL, &, Forsthuber TG, (2002) Pertussis toxin modulates the immune response to neuroantigens injected in incomplete Freund's adjuvant: induction of Th1 cells and experimental autoimmune encephalomyelitis in the presence of high frequencies of Th2 cells. J Immunol 169, 117-125. (Pubitemid 34686127)
128. Mu HH, &, Sewell WA, (1994) Regulation of DTH and IgE responses by IL-4 and IFN-gamma in immunized mice given pertussis toxin. Immunology 83, 639-645. (Pubitemid 24374099)
129. Chen X, Howard OM, &, Oppenheim JJ, (2007) Pertussis toxin by inducing IL-6 promotes the generation of IL-17-producing CD4 cells. J Immunol 178, 6123-6129. (Pubitemid 46717393)
130. Hofstetter HH, Grau C, Buttmann M, Forsthuber TG, Gaupp S, Toyka KV, &, Gold R, (2007) The PLPp-specific T-cell population promoted by pertussis toxin is characterized by high frequencies of IL-17-producing cells. Cytokine 40, 35-43. (Pubitemid 350088499)
131. Andreasen C, Powell DA, &, Carbonetti NH, (2009) Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice. PLoS ONE 4, e7079.
132. Skerry CM, &, Mahon BP, (2011) A live, attenuated Bordetella pertussis vaccine provides long-term protection against virulent challenge in a murine model. Clin Vaccine Immunol 18, 187-193.
133. Cassan C, Piaggio E, Zappulla JP, Mars LT, Couturier N, Bucciarelli F, Desbois S, Bauer J, Gonzalez-Dunia D, &, Liblau RS, (2006) Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cells. J Immunol 177, 1552-1560. (Pubitemid 44092489)
134. Chen X, Winkler-Pickett RT, Carbonetti NH, Ortaldo JR, Oppenheim JJ, &, Howard OM, (2006) Pertussis toxin as an adjuvant suppresses the number and function of CD4+CD25+ T regulatory cells. Eur J Immunol 36, 6716-6780.
135. Murphey C, Chang S, Zhang X, Arulanandam B, &, Forsthuber TG, (2011) Induction of polyclonal CD8+ T cell activation and effector function by pertussis toxin. Cell Immunol 267, 50-55.
136. Mielcarek N, Riveau G, Remoué F, Antoine R, Capron A, &, Locht C, (1998) Homologous and heterologous protection after single intransal administration of live attenuated recombinant Bordetella pertussis. Nat Biotechnol 16, 454-457. (Pubitemid 28211198)
137. Sato Y, Arai H, &, Suzuki K, (1974) Leukocytosis-promoting factor of Bordetella pertussis. III. Its identity with protective antigens. Infect Immun 9, 801-810.
138. Taranger J, Trollfors B, Bergfors E, Knutsson N, Lagergã¥rd T, Schneerson R, &, Robbins JB, (2001) Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine. Pediatrics 108, e115.
139. Robbins JB, Schneerson R, Keith JM, Shiloach J, Miller M, &, Trollors B, (2007) The rise in pertussis cases urges replacement of chemically- inactivated with genetically-inactivated toxoid for DTP. Vaccine 25, 2811-2816. (Pubitemid 46412573)
140. Storsaeter J, Wolter J, &, Locht C, (2007) Pertussis vaccines. In Bordetella Molecular Microbiology (, Locht C, ed.), pp. 245-288. Bioscience, Norfolk, UK.
141. Sekura RD, Fish F, Manclark CR, Meade B, &, Zhang YL, (1983) Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. J Biol Chem. 258, 14647-14651.
142. Imaizumi A, Suzuki Y, Ono S, Sato H, &, Sato Y, (1983) Effect of heptakis (2,6-O-dimethyl) beta-cyclodextrin on the production of pertussis toxin by Bordetella pertussis. Infect Immun 41, 1138-1143. (Pubitemid 13049293)
143. Thalen M, Venema M, van den IJssel J, Berwald L, Beuvery C, Martens D, &, Tramper J, (2006) Effect of relevant culture parameters on pertussis toxin expression by Bordetella pertussis. Biologicals 34, 213-220. (Pubitemid 44216164)
144. Thalen M, Venema M, Dekker A, Berwald L, van den IJssel J, Zomer B, Beuvery C, Martens D, &, Tramper J, (2006) Fed-batch cultivation of Bordetella pertussis: metabolism and pertussis toxin production. Biologicals 34, 289-297. (Pubitemid 44750690)
145. Gupta RK, Sharma SB, Ahuja S, &, Saxena SN, (1987) Glutaraldehyde inactivated pertussis vaccine: a less histamine sensitizing vaccine. J Biol Stand 15, 159-164. (Pubitemid 17122047)
146. Ibsen PH, (1996) The effect of formaldehyde, hydrogen peroxide and genetic detoxification of pertussis toxin on epitope recognition by murine monoclonal antibodies. Vaccine 14, 359-368. (Pubitemid 26151870)
147. Pizza M, Covacci A, Bartoloni A, Perugini M, Nencioni L, De Magistris MT, Villa L, Nucci D, Manetti R, Bugnoli M, et al. (1989) Mutants of pertussis toxin suitable for vaccine development. Science 246, 497-500. (Pubitemid 19273940)
148. Sato H, &, Sato Y, (1999) Experience with diphtheria toxoid-tetanus toxoid acellular pertussis vaccine in Japan. Clin Infect Dis 28 (Suppl 2), S124-S130. (Pubitemid 29270381)
149. Brown DR, Keith JM, Sato H, &, Sato Y, (1991) Construction and characterization of genetically inactivated pertussis toxin. Dev Biol Stand 73, 63-73.
150. Mielcarek N, Debrie AS, Raze D, Bertout J, Rouanet C, Younes AB, Creusy C, Engle J, Goldman WE, &, Locht C, (2006) Live attenuated B. pertussis as a single-dose nasal vaccine against whooping cough. PLoS Pathog 2, e65.
151. Feunou PF, Bertout J, &, Locht C, (2010) T- and B-cell-mediated protection induced by novel, live attenuated pertussis vaccine in mice. Cross protection against parapertusiss. PLoS One 5, e10178.
152. Feunou PF, Kammoun H, Debrie AS, Mielcarek N, &, Locht C, (2010) Long-term immunity against pertussis induced by a single nasal administration of live attenuated B. pertussis BPZE1. Vaccine 28, 7047-7053.
153. Mielcarek N, Debrie AS, Mahieux S, &, Locht C, (2010) Dose response of attenuated Bordetella pertussis BPZE1-induced protection in mice. Clin Vaccine Immunol 17, 317-324.